Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04540484 · ClinicalTrials.gov registry record
COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
A clinical trial of Covid19 and SARS-CoV Infection, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 507
- Enrollment target
- 1
- Study location
NCT04540484 is a study of Covid19 and SARS-CoV Infection that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 507 participants, below the 2,697-participant average among 94 other Covid19 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04540484, a study of Covid19 and SARS-CoV Infection, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 507 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a community hospital-based study that will enhance information being obtained in similar studies taking place in France, Denmark, and China. These studies are designed to assess risk of healthcare workers during outbreaks of Coronavirus 2019 (COVID-19) also known as sudden acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). This will be a prospective, single-center observational study involving human subjects. IgG (Immunoglobulin G) antibody will be tested in the serum of physicians working at Advocate Lutheran General Hospital (ALGH). IgG antibodies are the antibodies that form in response to viral or bacterial infections and typically reflect protection against said infection. To date, there have been no studies confirming that IgG antibody formation confers immunity, but studies are ongoing. Furthermore, data is lacking showing conclusive persistence of (possibly protective) antibodies over time. Attending physicians on the medical staff, fellow physicians, and house staff residents who worked at ALGH from March 1st, 2020 and on, will be eligible for the study. Testing will involve a venipuncture to obtain approximately 3mL of blood to be sent to ACL Laboratories for SARS-CoV-2 IgG testing. For physician subjects, this will be performed on four separate occasions, once at the onset of the study, a second test 3 months after the first test, a third test 6 months from the time of the first test, and a fourth and final test 12 months after the initial test. Two household members (defined below), one-time testing will occur within 2 weeks of the physician subject testing positive. All testing will be performed in a two-week window. All physician subjects will be tested at a centralized site that is only serving these subjects, by appointment. We will be offloading testing for household members to one localized commercial ACL site on the ALGH campus at the Center for Advanced Care. The household member testing will be extended to an additional two-wee
Conditions Studied
Interventions
- OTHER Screening
Study Locations (1)
Illinois
- Advocate Lutheran General Hospital - Park Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 507 participants |
| Start Date | 2020-08-26 |
| Est. Completion | 2021-12-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04540484
The ClinicalTrials.gov registry entry for NCT04540484 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 507 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,697-participant average among 94 other Covid19 trials with a reported enrollment target (81% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Screening is the first listed.
NCT04540484 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04540484 about?
NCT04540484 is a clinical study titled "COVID-19 IgG Formation in Physicians at ALGH and Their Household Members". This study is a community hospital-based study that will enhance information being obtained in similar studies taking place in France, Denmark, and China. These studies are designed to assess risk of healthcare workers during outbreaks of Coronavirus 2019 (COVID-19) also known as sudden acute respir...
What is the current status of trial NCT04540484?
This trial is currently completed. The enrollment target is 507 participants. The study started on 2020-08-26. Estimated completion is 2021-12-14.
What conditions does trial NCT04540484 study?
This clinical trial studies the following conditions: Covid19, SARS-CoV Infection, Communicable Disease.
What interventions are being tested in trial NCT04540484?
The interventions under investigation include: Screening (OTHER).
Who is sponsoring clinical trial NCT04540484?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04540484 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.